Cannabidiol (CBD) is a compound in cannabis that has medical effects but does not make people feel “stoned” and can actually counter the psychoactive effects of THC. After decades in which only high-THC Cannabis was available, CBD-rich strains are now being grown by and for medical users.
The reduced psychoactivity of CBD-rich cannabis makes it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, and anti-psychotic effects without disconcerting lethargy or dysphoria.
Scientific studies underscore CBD’s potential as a treatment for many conditions, including chronic pain, diabetes, cancer, cardiovascular disease, alcoholism, PTSD, schizophrenia, antibiotic-resistant infections, rheumatoid arthritis, MS, epilepsy, and other neurological disorders.
After decades in which only high-THC cannabis was available, CBD-rich strains and products are now accessible to medical users. Project CBD networks with providers in states and countries where cannabis products are legal for therapeutic use.
By Martin A. Lee (The Nation). For many years, the federal government has subsidized studies designed to prove the negative effects of marijuana, while blocking inquiry into its potential benefits. Ironically, the government’s steadfast search for harm has yielded remarkable scientific insights that explain why cannabis is such a versatile remedy.
By Adrian Devitt-Lee & Martin A. Lee. There is growing interest among medical scientists in the gene-regulating properties of cannabidiol (CBD), the non-psychoactive plant cannabinoid. CBD reduces brain cancer and breast cancer cell proliferation and metastasis by inhibiting the expression of the ID-1 gene.
- Antibiotic resistance
- Endocrine disorders
- Heart disease
- Irritable bowel
- Kidney disease
- Liver disease
- Metabolic syndrome
- Mood disorders
- Motion sickness
- Multiple sclerosis
- Neuropathic pain